Jorge J. Castillo, M.D. | Management of Waldenström Macroglobulinemia in 2022 |
03/17/2022 - 8:00am to 9:00am |
P. Leif Bergsagel, M.D., FASCO | Treatment of Multiple Myeloma: Where do we go from here? |
03/24/2022 - 8:00am to 9:00am |
Phillip H. Kuo, M.D., Ph.D. | Prostate-specific Membrane Antigen-Targeted Theranostics |
03/31/2022 - 8:00am to 9:00am |
Fergus J. Couch, Ph.D. | Inherited Susceptibility to Breast Cancer |
04/07/2022 - 8:00am to 9:00am |
Michael E. Wolf, M.D., M.S. | Hyperbaric Oxygen Therapy: Treatment Considerations and Utilization in the Oncology Patient |
04/14/2022 - 8:00am to 9:00am |
Carlos H. Barrios, M.D. | Academic Research in Oncology: Global Challenges |
05/05/2022 - 8:00am to 9:00am |
Felipe Batalini, M.D. | Mutational Signature 3 from Clinical Sequencing as Predictor of Response to PARPi |
05/12/2022 - 8:00am to 9:00am |
Josep Dalmau, M.D., Ph.D., FAAN | Autoimmune Encephalitis |
05/19/2022 - 8:00am to 9:00am |
John D. Halamka, M.D., M.S. and Maneesh Goyal | Emerging Technology Platforms in Health Care |
06/02/2022 - 8:00am to 9:00am |
Stephen J. Russell M.B.Ch.B., Ph.D., FRCP (UK), FRCPath (UK), LLD (Hon). Viruses to the Rescue: Discovering, Translating and Commercially Developing Mayo’s Anticancer Viruses | |
06/09/2022 - 8:00am to 9:00am |